QuidelOrtho Corporation (LON:0A55)

Market Cap	593.28M -43.5%
Revenue (ttm)	1.96B -4.5%
Net Income	-278.84M
EPS	-4.05
Shares Out	n/a
PE Ratio	n/a
Forward PE	11.73
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25
Open	13.56
Previous Close	43.50
Day's Range	13.56 - 13.56
52-Week Range	13.56 - 13.56
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 3, 2026

About QuidelOrtho

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1979
• Employees: 6,500
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A55

Financial Performance

In 2025, QuidelOrtho's revenue was $2.73 billion, a decrease of -1.89% compared to the previous year's $2.78 billion. Losses were -$1.13 billion, -44.84% less than in 2024.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error